Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Impact of preoperative prostate magnetic resonance imaging on the surgical management of high-risk prostate cancer.

Baack Kukreja J, Bathala TK, Reichard CA, Troncoso P, Delacroix S, Davies B, Eggener S, Smaldone M, Minhaj Siddiqui M, Tollefson M, Chapin BF.

Prostate Cancer Prostatic Dis. 2019 Sep 9. doi: 10.1038/s41391-019-0171-0. [Epub ahead of print]

PMID:
31501508
2.

MRI Displays the Prostatic Cancer Anatomy and Improves the Bundles Management Before Robot-Assisted Radical Prostatectomy.

Schiavina R, Bianchi L, Borghesi M, Dababneh H, Chessa F, Pultrone CV, Angiolini A, Gaudiano C, Porreca A, Fiorentino M, De Groote R, D'Hondt F, De Naeyer G, Mottrie A, Brunocilla E.

J Endourol. 2018 Apr;32(4):315-321. doi: 10.1089/end.2017.0701.

PMID:
29256639
3.

Preoperative multiparametric MRI of the prostate for the prediction of lymph node metastases in prostate cancer patients treated with extended pelvic lymph node dissection.

Brembilla G, Dell'Oglio P, Stabile A, Ambrosi A, Cristel G, Brunetti L, Damascelli A, Freschi M, Esposito A, Briganti A, Montorsi F, Del Maschio A, De Cobelli F.

Eur Radiol. 2018 May;28(5):1969-1976. doi: 10.1007/s00330-017-5229-6. Epub 2017 Dec 21.

PMID:
29270644
4.

3.0-T multiparametric magnetic resonance imaging modifies the template of endoscopic, conventional radical prostatectomy in all cancer risk categories
.

Kozikowski M, Powroźnik J, Malewski W, Kawecki S, Piotrowicz S, Michalak W, Nyk Ł, Gola M, Dobruch J.

Arch Med Sci. 2018 Oct;14(6):1387-1393. doi: 10.5114/aoms.2018.77222. Epub 2018 Jul 17.

5.

Prostate Imaging Reporting and Data System in prostate cancer staging and planning for radical prostatectomy.

Kozikowski M, Zagożdżon B, Gola M, Dobruch J.

Wideochir Inne Tech Maloinwazyjne. 2019 Apr;14(2):262-270. doi: 10.5114/wiitm.2019.83869. Epub 2019 Mar 26.

6.

Comparison of 68Ga-PSMA-11 PET-CT with mpMRI for preoperative lymph node staging in patients with intermediate to high-risk prostate cancer.

Zhang Q, Zang S, Zhang C, Fu Y, Lv X, Zhang Q, Deng Y, Zhang C, Luo R, Zhao X, Wang W, Wang F, Guo H.

J Transl Med. 2017 Nov 7;15(1):230. doi: 10.1186/s12967-017-1333-2.

7.

Multiparametric magnetic resonance imaging for the assessment of extracapsular invasion and other staging parameters in patients with prostate cancer candidates for radical prostatectomy.

Lista F, Gimbernat H, Cáceres F, Rodríguez-Barbero JM, Castillo E, Angulo JC.

Actas Urol Esp. 2014 Jun;38(5):290-7. doi: 10.1016/j.acuro.2013.11.003. Epub 2014 Jan 1. English, Spanish.

PMID:
24387827
8.

Toward Prostate Cancer Contouring Guidelines on Magnetic Resonance Imaging: Dominant Lesion Gross and Clinical Target Volume Coverage Via Accurate Histology Fusion.

Gibson E, Bauman GS, Romagnoli C, Cool DW, Bastian-Jordan M, Kassam Z, Gaed M, Moussa M, Gómez JA, Pautler SE, Chin JL, Crukley C, Haider MA, Fenster A, Ward AD.

Int J Radiat Oncol Biol Phys. 2016 Sep 1;96(1):188-96. doi: 10.1016/j.ijrobp.2016.04.018. Epub 2016 Apr 21.

PMID:
27375167
10.

What Is the Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in Excluding Prostate Cancer at Biopsy? A Systematic Review and Meta-analysis from the European Association of Urology Prostate Cancer Guidelines Panel.

Moldovan PC, Van den Broeck T, Sylvester R, Marconi L, Bellmunt J, van den Bergh RCN, Bolla M, Briers E, Cumberbatch MG, Fossati N, Gross T, Henry AM, Joniau S, van der Kwast TH, Matveev VB, van der Poel HG, De Santis M, Schoots IG, Wiegel T, Yuan CY, Cornford P, Mottet N, Lam TB, Rouvière O.

Eur Urol. 2017 Aug;72(2):250-266. doi: 10.1016/j.eururo.2017.02.026. Epub 2017 Mar 21. Review.

PMID:
28336078
11.

Multiparametric MRI for prostate cancer: a national survey of patterns of practice among radiation oncologists in Spain.

Couñago F, Sancho G, Gómez-Iturriaga A, Henríquez I; Urological Tumours Working Group of the Spanish Society of Radiation Oncology (URONCOR/SEOR).

Clin Transl Oncol. 2018 Nov;20(11):1484-1491. doi: 10.1007/s12094-018-1919-z. Epub 2018 Jul 10.

PMID:
29992463
12.

Magnetic resonance imaging in prostate cancer detection and management: a systematic review.

Monni F, Fontanella P, Grasso A, Wiklund P, Ou YC, Randazzo M, Rocco B, Montanari E, Bianchi G.

Minerva Urol Nefrol. 2017 Dec;69(6):567-578. doi: 10.23736/S0393-2249.17.02819-3. Epub 2017 May 8. Review.

13.

Detection of recurrent prostate cancer after primary radiation therapy: An evaluation of the role of multiparametric 3T magnetic resonance imaging with endorectal coil.

Zattoni F, Kawashima A, Morlacco A, Davis BJ, Nehra AK, Mynderse LA, Froemming AT, Jeffrey Karnes R.

Pract Radiat Oncol. 2017 Jan - Feb;7(1):42-49. doi: 10.1016/j.prro.2016.06.003. Epub 2016 Jun 14.

PMID:
27527896
15.

The efficacy and utilisation of preoperative multiparametric magnetic resonance imaging in robot-assisted radical prostatectomy: does it change the surgical dissection plan?

Tavukçu HH, Aytaç Ö, Balcı NC, Kulaksızoğlu H, Atuğ F.

Turk J Urol. 2017 Dec;43(4):470-475. doi: 10.5152/tud.2017.35589. Epub 2017 Dec 1.

16.

Impact of multiparametric magnetic resonance imaging on risk group assessment of patients with prostate cancer addressed to external beam radiation therapy.

Pullini S, Signor MA, Pancot M, Zuiani C, Bazzocchi M, Fongione S, Girometti R.

Eur J Radiol. 2016 Apr;85(4):764-70. doi: 10.1016/j.ejrad.2016.01.008. Epub 2016 Jan 21.

PMID:
26971421
17.

Multiparametric magnetic resonance imaging for prostate cancer: A review and update for urologists.

Yoo S, Kim JK, Jeong IG.

Korean J Urol. 2015 Jul;56(7):487-97. doi: 10.4111/kju.2015.56.7.487. Epub 2015 Jun 30. Review.

18.

A Novel Nomogram to Identify Candidates for Extended Pelvic Lymph Node Dissection Among Patients with Clinically Localized Prostate Cancer Diagnosed with Magnetic Resonance Imaging-targeted and Systematic Biopsies.

Gandaglia G, Ploussard G, Valerio M, Mattei A, Fiori C, Fossati N, Stabile A, Beauval JB, Malavaud B, Roumiguié M, Robesti D, Dell'Oglio P, Moschini M, Zamboni S, Rakauskas A, De Cobelli F, Porpiglia F, Montorsi F, Briganti A.

Eur Urol. 2019 Mar;75(3):506-514. doi: 10.1016/j.eururo.2018.10.012. Epub 2018 Oct 17.

PMID:
30342844
19.

Multiparametric magnetic resonance imaging versus Partin tables and the Memorial Sloan-Kettering cancer center nomogram in risk stratification of patients with prostate cancer referred to external beam radiation therapy.

Girometti R, Pancot M, Signor MA, Urbani M, Balestreri L, Zuiani C.

Radiol Med. 2018 Oct;123(10):778-787. doi: 10.1007/s11547-018-0903-6. Epub 2018 May 12.

PMID:
29752647
20.

Prospective Study of the Radiolabeled GRPR Antagonist BAY86-7548 for Positron Emission Tomography/Computed Tomography Imaging of Newly Diagnosed Prostate Cancer.

Touijer KA, Michaud L, Alvarez HAV, Gopalan A, Kossatz S, Gonen M, Beattie B, Sandler I, Lyaschenko S, Eastham JA, Scardino PT, Hricak H, Weber WA.

Eur Urol Oncol. 2019 Mar;2(2):166-173. doi: 10.1016/j.euo.2018.08.011. Epub 2018 Sep 22.

PMID:
31017093

Supplemental Content

Support Center